123 related articles for article (PubMed ID: 8471199)
1. Elevated serum levels of neopterin but not beta 2-microglobulin in HIV-1-seronegative injecting drug users.
Strickler HD; Blanchard JF; Vlahov D; Taylor E; Muñoz A; Nelson KE; Margolick JB
AIDS; 1993 Mar; 7(3):361-7. PubMed ID: 8471199
[TBL] [Abstract][Full Text] [Related]
2. Close relationships between neopterin and beta-2-microglobulin levels in intravenous drug abusers.
Lin RY; Nygren E; Valinsky J; Lorenzana FG; Ralph H
Int Arch Allergy Appl Immunol; 1990; 91(4):389-93. PubMed ID: 1976599
[TBL] [Abstract][Full Text] [Related]
3. The effect of zidovudine treatment on serum neopterin and beta 2-microglobulin levels in mildly symptomatic, HIV type 1 seropositive individuals.
Bass HZ; Hardy WD; Mitsuyasu RT; Taylor JM; Wang YX; Fischl MA; Spector SA; Richman DD; Fahey JL
J Acquir Immune Defic Syndr (1988); 1992; 5(3):215-21. PubMed ID: 1346807
[TBL] [Abstract][Full Text] [Related]
4. Immune serum markers and CD4 cell counts in HIV-infected intravenous drug users.
Chaisson RE; Taylor E; Margolick JB; Muñoz A; Solomon L; Cohn S; Nelson KE; Vlahov D
J Acquir Immune Defic Syndr (1988); 1992; 5(5):456-60. PubMed ID: 1348535
[TBL] [Abstract][Full Text] [Related]
5. Serum concentrations of circulating endogenous granulocyte-macrophage colony-stimulating factor in HIV-1-seropositive injecting drug users.
Herold M; Meise U; Günther V; Rössler H; Zangerle R
Presse Med; 1994 Dec; 23(40):1854-8. PubMed ID: 7899316
[TBL] [Abstract][Full Text] [Related]
6. Clinical and laboratory predictors of survival in Gambian patients with symptomatic HIV-1 or HIV-2 infection.
Whittle H; Egboga A; Todd J; Corrah T; Wilkins A; Demba E; Morgan G; Rolfe M; Berry N; Tedder R
AIDS; 1992 Jul; 6(7):685-9. PubMed ID: 1354448
[TBL] [Abstract][Full Text] [Related]
7. Factors influencing serum neopterin and beta 2-microglobulin levels in a healthy diverse population.
Diamondstone LS; Tollerud DJ; Fuchs D; Wachter H; Brown LM; Maloney E; Kurman CC; Nelson DL; Blattner WA
J Clin Immunol; 1994 Nov; 14(6):368-74. PubMed ID: 7883864
[TBL] [Abstract][Full Text] [Related]
8. ["Prognostic markers" in serum of active and passive intravenous drug users infected with human immunodeficiency virus (HIV)].
Rogowska-Szadkowska D; Borzuchowska A; Prokopowicz D; Chodynicka B; Rogowski F; Kramarz P
Pol Arch Med Wewn; 1995 Jun; 93(6):469-74. PubMed ID: 7491346
[TBL] [Abstract][Full Text] [Related]
9. Association of immune activation with intravenous heroin use and methadone treatment in HIV-1 seropositive and seronegative subjects.
Di Franco MJ; Marlink R; Hunter DJ; Tosteson T; Mayer K; Essex M
J Acquir Immune Defic Syndr (1988); 1993 Dec; 6(12):1297-300. PubMed ID: 8254465
[TBL] [Abstract][Full Text] [Related]
10. Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I.
AIDS; 1994 Jul; 8(7):911-21. PubMed ID: 7946100
[TBL] [Abstract][Full Text] [Related]
11. Immunologic marker paths for seroconversion: single determinations of immunoglobulin A and beta 2-microglobulin are not adequate to estimate time of HIV infection. Multicohort Analysis Project Workshop. Part II.
AIDS; 1994 Jul; 8(7):923-33. PubMed ID: 7946101
[TBL] [Abstract][Full Text] [Related]
12. Intrathecal production of neopterin and beta 2 microglobulin in tick-borne encephalitis (TBE) compared to meningoencephalitis of other etiology.
Günther G; Haglund M; Lindquist L; Sköldenberg B; Forsgren M
Scand J Infect Dis; 1996; 28(2):131-8. PubMed ID: 8792478
[TBL] [Abstract][Full Text] [Related]
13. Neopterin, beta 2-microglobulin, and acute phase proteins in HIV-1-seropositive and -seronegative Zambian patients with tuberculosis.
Hosp M; Elliott AM; Raynes JG; Mwinga AG; Luo N; Zangerle R; Pobee JO; Wachter H; Dierich MP; McAdam KP; Fuchs D
Lung; 1997; 175(4):265-75. PubMed ID: 9195554
[TBL] [Abstract][Full Text] [Related]
14. Beta 2-microglobulin levels in drug users: the influence of risk behaviour.
Flegg PJ; Brettle RP; Robertson JR; Clarkson RC; Bird AG
AIDS; 1991 Aug; 5(8):1021-4. PubMed ID: 1777161
[TBL] [Abstract][Full Text] [Related]
15. Changes in serum neopterin and serum beta 2-microglobulin in subjects with lung infections.
Carstens J; Andersen PL
Eur Respir J; 1994 Jul; 7(7):1233-8. PubMed ID: 7925900
[TBL] [Abstract][Full Text] [Related]
16. Serum levels of soluble CD8, neopterin, beta 2-microglobulin and p24 antigen as indicators of disease progression in children with AIDS on zidovudine therapy.
Siller L; Martin NL; Kostuchenko P; Beckett L; Rautonen J; Cheng SC; Wara DW
AIDS; 1993 Mar; 7(3):369-73. PubMed ID: 8097095
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.
Fahey JL; Taylor JM; Detels R; Hofmann B; Melmed R; Nishanian P; Giorgi JV
N Engl J Med; 1990 Jan; 322(3):166-72. PubMed ID: 1967191
[TBL] [Abstract][Full Text] [Related]
18. The 90K tumor-associated antigen and clinical progression in human immunodeficiency virus infection.
Iacobelli S; Ullrich A; Tinari N; Ortona L; Tamburrini E; D'Egidio M; Ghinelli F; Sighinolfi L; Piazza M; Chirianni A
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Dec; 10(4):450-6. PubMed ID: 7583441
[TBL] [Abstract][Full Text] [Related]
19. Relationship and prognostic value of endogenous interferon-alpha, beta 2-microglobulin, and neopterin serum levels in patients with Kaposi sarcoma and AIDS.
Krown SE; Niedzwiecki D; Bhalla RB; Flomenberg N; Bundow D; Chapman D
J Acquir Immune Defic Syndr (1988); 1991; 4(9):871-80. PubMed ID: 1895208
[TBL] [Abstract][Full Text] [Related]
20. Serum neopterin level predicts HIV-related mortality but not progression to AIDS or development of neurological disease in gay men and parenteral drug users.
Sacktor N; Liu X; Popescu M; Marder K; Stern Y; Mayeux R
Arch Neurol; 1995 Jul; 52(7):676-9. PubMed ID: 7619023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
